SCHEMBL6288056

SCHEMBL6288056

Cc1ccc2c(CC(=O)O)c(C)[nH]c2c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.77
MAPT P10636 5/20 0.77
GAA P10253 4/20 0.77
ALDH1A1 P00352 2/20 0.77
MEN1 O00255 2/20 0.77
KMT2A Q03164 2/20 0.77
CASP1 P29466 1/20 0.67
CASP7 P55210 1/20 0.67
POLB P06746 1/20 0.59
AKR1C2 P52895 1/20 0.57
EGFR P00533 1/20 0.56
MITF O75030 1/20 0.54
MPL P40238 1/20 0.50
RAB9A P51151 1/20 0.49
PIM1 P11309 1/20 0.49
PTGS2 P35354 3/20 0.48
PTGS1 P23219 1/20 0.48
ALOX15 P16050 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6102581 0.87 KDM4E (1.00) KDM4EMAPTGAAALDH1A1MEN1
SCHEMBL30854920 0.87 KDM4E (1.00) KDM4EMAPTGAAALDH1A1MEN1
SCHEMBL2004066 0.86 KDM4E (0.65) KDM4EMAPTGAAALDH1A1MEN1
SCHEMBL18509428 0.84 EGFR (0.72) KDM4EMAPTGAAALDH1A1MEN1
SCHEMBL31381374 0.84 KDM4E (0.63) KDM4EMAPTGAAALDH1A1MEN1
SCHEMBL6287665 0.84 KDM4E (0.63) KDM4EMAPTGAAALDH1A1MEN1
SCHEMBL6282260 0.83 MAPT (0.55) KDM4EMAPTGAAALDH1A1MEN1
SCHEMBL6290446 0.82 AKR1C2 (0.80) KDM4EMAPTGAAALDH1A1MEN1
SCHEMBL6290568 0.81 KDM4E (0.58) KDM4EMAPTGAAALDH1A1MEN1
SCHEMBL379103 0.80 KDM4E (1.00) KDM4EMAPTGAAALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK KDM4E 2972/4885MAPT 4866/4885GAA 4704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.